gillet01

GSK's Promatica Gets Thumbs Up on NDA

Remember that the FDA is staffed with , how can I say this, not the top level, of scientific minds. Clearly the reviewers who accepted the publication of the study results for NEJM thought it OK. That's why there is an independent panel. Any delay in approval is merely a face saving strategy at this point.